Bufalin Inhibits Cytokine Storm by Regulating TLR4/TLR3 Signaling Pathway
ABSTRACT Background Bufalin is one main component of the dried venom from Bufo gargarizans Cantor, which has anti‐tumor, cardiotonic, anti‐inflammatory and other physiological activities. However, in recent years, researchers have mainly paid attention to its anti‐tumor effect and neglected its anti‐inflammatory effect.
Xixi Liu +11 more
wiley +1 more source
Enhancement of sandy soil water retention using superabsorbent carboxymethyl cellulose grafted with polyacrylamide and polyacrylamidomethyl propanesulfonic acid copolymer. [PDF]
Abdelgelil AA +4 more
europepmc +1 more source
ABSTRACT Background Cachexia, characterized by severe weight loss and muscle atrophy, frequently occurs in chronic conditions such as sepsis, cancer and chemotherapy, with limited effective treatments. Despite similar clinical manifestations, the underlying mechanisms across different disease contexts remain unclear.
Qiquan Wang +15 more
wiley +1 more source
Pattern recognition receptors and inflammasome: Now and beyond. [PDF]
Oh S, Choi YK, Lee S.
europepmc +1 more source
The Role of Pyroptosis in Colorectal Cancer: From Mechanisms to Therapeutic Opportunities. [PDF]
Xie H, Deng X, Li Q.
europepmc +1 more source
Periprosthetic joint infection and heterotopic ossification after total hip arthroplasty: systematic review and meta-analysis. [PDF]
Pulik Ł +6 more
europepmc +1 more source
Roles of cytokine storm in sepsis progression: biomarkers, and emerging therapeutic strategies. [PDF]
You W.
europepmc +1 more source
Glucose Metabolism and Innate Immune Responses in Influenza Virus Infection: Mechanistic Insights and Clinical Perspectives. [PDF]
Awad K +7 more
europepmc +1 more source
A fungal cell wall elicitor from Neopestalotiopsis clavispora induces systemic defense in Ginkgo Biloba. [PDF]
Dong Y, Han S, Zhan J, Zhu T.
europepmc +1 more source
Lectin receptor kinase 79, a putative target of the Phytophthora infestans effector IPI-O [PDF]
Bouwmeester, K. +5 more
core +1 more source

